Clostridium difficile and Clostridium perfringens research

46 ta ish

The Role of Gut Microbiome Alterations in the Pathogenesis and Management of Rheumatoid Arthritis.
Oybek Khasanov, Nodirjon Khazratov
MaqolaGut microbiota and healthZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
THE IMPORTANCE OF MICROORGANISMS IN THE DEVELOPMENT OF GASTRITIS, PEPTIC ULCER DISEASE, AND COLITIS
Inoyatullo Kholmurodov, Ozoda Boboxonova
MaqolaHelicobacter pylori-related gastroenterology studiesZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
THE IMPORTANCE OF MICROORGANISMS IN THE DEVELOPMENT OF GASTRITIS, PEPTIC ULCER DISEASE, AND COLITIS
Inoyatullo Kholmurodov, Ozoda Boboxonova
MaqolaHelicobacter pylori-related gastroenterology studiesZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
THE IMPORTANCE OF MICROORGANISMS IN THE DEVELOPMENT OF GASTRITIS, PEPTIC ULCER DISEASE, AND COLITIS
Inoyatullo Kholmurodov, Ozoda Boboxonova
MaqolaHelicobacter pylori-related gastroenterology studiesZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
THE IMPORTANCE OF MICROORGANISMS IN THE DEVELOPMENT OF GASTRITIS, PEPTIC ULCER DISEASE, AND COLITIS
Inoyatullo Kholmurodov, Ozoda Boboxonova
MaqolaHelicobacter pylori-related gastroenterology studiesZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
Clarithromycin Resistance and Treatment Outcomes in <i>Helicobacter pylori</i> Infections: Molecular Genetic Study From Uzbekistan
J. A. Ismailova, Abrorjon Yusupbekov, Abrorjon Abdurakhimov +1
MaqolaHelicobacter pylori-related gastroenterology studiesGastroenterology Research and Practice20260 iqtibos
ABI
CLINICAL AND LABORATORY CHANGES IN THE LIVER THAT DEVELOP AGAINST THE BACKGROUND OF INTESTINAL DYSBACTERIOSIS
Musharraf Shodiyeva, Feruza Kaxxorova
MaqolaAmoebic Infections and TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
CLINICAL AND LABORATORY CHANGES IN THE LIVER THAT DEVELOP AGAINST THE BACKGROUND OF INTESTINAL DYSBACTERIOSIS
Musharraf Shodiyeva, Feruza Kaxxorova
MaqolaAmoebic Infections and TreatmentsZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
ZAMONAVIY TIBBIYOTDA KLASTRIDIAL INFEKSIYALARGA QARSHI KURASHISHNING INNOVATSION USULLARI
Samadova Charos Salim qizi
MaqolaClostridium difficile and Clostridium perfringens researchZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
ZAMONAVIY TIBBIYOTDA KLASTRIDIAL INFEKSIYALARGA QARSHI KURASHISHNING INNOVATSION USULLARI
Samadova Charos Salim qizi
MaqolaClostridium difficile and Clostridium perfringens researchZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
Correction of Colonic Microbiota Dysbiosis Using Synbiotics in Patients with Concurrent Obesity and Chronic Kidney Disease: Clinical Evidence, Mechanistic Insights, and Therapeutic Prospects
Charos Abdudjalilovna Abdullayeva, Malika Sanjarovna Islamova, Закирова Гульноза Алишеровна +3
MaqolaGut microbiota and healthInternational Journal of Drug Delivery Technology20260 iqtibos
ABI
INNOVATIVE METHODS OF COMBATING CLASTRIDIAL INFECTIONS IN MODERN MEDICINE
Charos Samadova
MaqolaClostridium difficile and Clostridium perfringens researchJournal of Universal Science Research20260 iqtibos
ABI
Changes in intestinal flora depending on the stage of HIV infection, viral load and CD4-cell count
L. N. Tuychiev, Sh. B. Rakhmatullaeva, K. P. Nasirova +1
MaqolaGut microbiota and healthHIV Infection and Immunosuppressive Disorders20260 iqtibos
ABI
CHANGES IN THE IMMUNE SYSTEM IN DISEASES OF BACTERIAL ETIOLOGY AND MEASURES TO PREVENT AND ELIMINATE THE CHANGES THAT OCCUR
Nigora Sabitovna Gafurova, Nigina Talat kizi Ilyosboeva
MaqolaGut microbiota and healthZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
CHANGES IN THE IMMUNE SYSTEM IN DISEASES OF BACTERIAL ETIOLOGY AND MEASURES TO PREVENT AND ELIMINATE THE CHANGES THAT OCCUR
Nigora Sabitovna Gafurova, Nigina Talat kizi Ilyosboeva
MaqolaGut microbiota and healthZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
THE EFFECT OF PRE-HOSPITAL ANTIMICROBIAL THERAPY ON GUT MICROBIOTA INDICATORS IN PATIENTS WITH INFECTIOUS COLITIS
Shonazarovich Shomuratov Abror, Abdukadirovna Nuruzova Zukhra, Abror Asrorovich Xamraev +1
MaqolaClostridium difficile and Clostridium perfringens researchZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
THE EFFECT OF PRE-HOSPITAL ANTIMICROBIAL THERAPY ON GUT MICROBIOTA INDICATORS IN PATIENTS WITH INFECTIOUS COLITIS
Shonazarovich Shomuratov Abror, Abdukadirovna Nuruzova Zukhra, Abror Asrorovich Xamraev +1
MaqolaClostridium difficile and Clostridium perfringens researchZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
ULCERATIVE COLITIS: ETIOLOGICAL FACTORS, PATHOGENETIC MECHANISMS, DIAGNOSTIC APPROACHES, CONTEMPORARY THERAPEUTIC STRATEGIES, AND PREVENTION
Umed Zayniddin ugli Nuriddinov
MaqolaInflammatory Bowel DiseaseZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
ULCERATIVE COLITIS: ETIOLOGICAL FACTORS, PATHOGENETIC MECHANISMS, DIAGNOSTIC APPROACHES, CONTEMPORARY THERAPEUTIC STRATEGIES, AND PREVENTION
Umed Zayniddin ugli Nuriddinov
MaqolaInflammatory Bowel DiseaseZenodo (CERN European Organization for Nuclear Research)20260 iqtibos
ABI
Methodological concerns in the association between gut microbiota and sarcopenia: from cross‑sectional associations to statistical fragility
Sharipova Gulnihol, Nurullaev Abdukhamid, Turakulov Rustam +2
MaqolaGut microbiota and healthAging Clinical and Experimental Research20260 iqtibos
ABI
Inflammatory bowel disease burden in the age of 25-35 years: a comprehensive analysis of incidence, prevalence, and mortality.
Muhammad Fawad, Ali Raza, Nadeem Bajkani +4
MaqolaInflammatory Bowel DiseaseInternational Journal of Drug Delivery Technology20260 iqtibos
ABI